Login | Register

Obesity Drug Lorcaserin Gets Positive Vote From FDA Panel

Lorcaserin, an investigational obesity drug, was given a positive recommendation by the Endocrinologic and Metabolic Drugs Advisory Committee, which advises the Food and Drug Administration (FDA). The Committee voted 18 to 4 in favor, with one abstention, in advising the FDA whether to approve the medication for obese or overweight individuals...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *